Lupin's share price plunged by nearly 4 per cent on Tuesday after the company announced its Q4FY24 results. The Indian multinational Pharmaceutical company witnessed an increase of 52 per cent in its net profit to Rs 359 crore from Rs 236 crore recorded in the corresponding quarter of the previous year.